Claudia Crippa

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Michèle Cavo, Paola Tacchetti, Francesca Patriarca et al. · The Lancet · 2010 · 820 citations

Medicine, Hematology, Pharmacotherapy +17

Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Antonio Palumbo, Federica Cavallo, Francesca Gay et al. · New England Journal of Medicine · 2014 · 781 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial

Antonio Palumbo, Michèle Cavo, Elena Zamagni et al. · Journal of Clinical Oncology · 2011 · 322 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

Antonio Palumbo, Patrizia Falco, Paolo Corradini et al. · Journal of Clinical Oncology · 2007 · 317 citations

Medicine, Pharmacology, Pharmacotherapy +15

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Michèle Cavo, Lucia Pantani, Maria Teresa Petrucci et al. · Blood · 2012 · 309 citations · Full text

Medicine, Hematology, Pharmacotherapy +16